We are live on ! Find out more
NEO icon

NeoGenomics

285 hedge funds and large institutions have $3.17B invested in NeoGenomics in 2020 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 104 increasing their positions, 84 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more call options, than puts

Call options by funds: $8.14M | Put options by funds: $3.27M

53% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 32

24% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 84

22% more capital invested

Capital invested by funds: $2.61B → $3.17B (+$565M)

5% more funds holding

Funds holding: 272285 (+13)

3.14% more ownership

Funds ownership: 90.09%93.23% (+3.1%)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

Holders
285
Holders Change
+13
Holders Change %
+4.78%
% of All Funds
5.83%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.16%
New
49
Increased
104
Reduced
84
Closed
32
Calls
$8.14M
Puts
$3.27M
Net Calls
+$4.87M
Net Calls Change
+$4.11M

NEO Hedge Fund Activity: Q2 2020 in Review

285 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2020, worth a combined $3.17B — up 22% from $2.61B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new NEO positions and 32 closed out — a net gain of 17 holders — while 104 added to existing stakes and 84 trimmed.

The largest buyer was Artisan Partners, adding an estimated $41.9M. The largest seller was Eagle Asset Management, cutting an estimated $15.7M.

  • 285 institutional investors held NeoGenomics (NEO) as of Q2 2020, up from 272 in Q1 2020.
  • Funds reported $3.17B of NeoGenomics stock for Q2 2020, up 22% quarter-over-quarter.
  • 49 funds opened new NeoGenomics positions in Q2 2020 and 32 closed out, a net change of +17 holders.
  • The largest NeoGenomics buyer in Q2 2020 was Artisan Partners, an estimated $41.9M added.
  • The largest NeoGenomics seller in Q2 2020 was Eagle Asset Management, an estimated $15.7M sold.

Based on aggregated 13F filings for Q2 2020.